Description: Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers automatic detection instruments, including coagulation, hemorheology, hematocrit, and platelet aggregation, as well as supporting reagents and consumables. Its products are used in the prevention, screening, diagnosis, and monitoring of stroke, coronary heart disease, venous thromboembolism, and other thrombotic and bleeding diseases. The company was founded in 2003 and is based in Beijing, China.
Home Page: www.succeeder.com.cn
Building CC-11
Beijing,
102206
China
Phone:
86 10 5385 5568
Officers
| Name | Title |
|---|---|
| Mr. Hai Wang | GM & Director |
| Mr. Guo Li | Financial Director & Director |
| Ms. Zhonghui Ding | Deputy GM & Director |
| Mr. Xiaofeng Gu | Deputy GM & Director |
| Mr. Jiahong Zhang | Board Sec. |
| Mr. Yanbin Pei | Deputy Gen. Mang. |
| Mr. Li Gang | Core Technical Staff |
| Ms. Lijun Zhang | Core Technical Staff |
Exchange: SHG
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 29.7955 |
| Price-to-Book MRQ: | 1.9376 |
| Price-to-Sales TTM: | 11.9202 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 266 |